-Frontline Reinstatement of the fundamental right to property in the Constitution will on its own do little to protect the interests of poor peasants and traditional communities.  The Indian Constitution adopted in 1950 guaranteed a set of fundamental rights that cannot be abridged by Central or State laws. One of these fundamental rights was the right to property enshrined in Articles 19(1)(f) and 31. Article 19(1)(f) guaranteed to all citizens the right...

-The Hindustan Times In the face of public outrage over a series of unpopular fiscal steps such as hike in diesel prices and cap on LPG, the government plans to come out with two feel-good initiatives — the food security bill and health cover for all. The UPA’s flagship National Food Security Bill would give 67% of the population (nearly 800 million people) a legal right to foodgrains at less than half the...

-Outlook The Delhi University today assured the high court here that it would ensure punctuality among its teachers and install biometric attendance register system in its various colleges. "The university is committed to implementation of the biometric system, said the Delhi University (DU) registrar in an affidavit to the Delhi High Court bench of Acting Chief Justice A K Sikri and Justice Rajiv Sahai Endlaw. Accepting DU's assurance, the bench today disposed of...

-The Indian Express Mining in India has come a long way in the last 50 years or so. From the Industrial Policy Resolution of 1957 to the National Mineral Policy (NMP) of 1993, and now to the NMP of 2008, it has shown a progressive shift towards bringing the private sector into exploration, mining and downstream value addition. However, the regulatory systems perhaps never managed to keep pace with developments on...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...